26.61 0.00 (0.00%)

New 52W High today

550 BSE Volume

BSE 24 Mar, 2025 3:31 PM (IST)



Board Meetings - Novelix Pharmaceuticals Ltd.

The latest board meeting for Novelix Pharmaceuticals Ltd. took place on 12 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
12 Feb 2025 Quarterly Results -
13 Nov 2024 Quarterly Results & Others Inter-alia, 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024.
21 Oct 2024 To consider issue of Warrants (Revised)
02 Sep 2024 Others Inter alia, to consider 1. Amendment of Main Objects of the Company. 2. Change in name of the Company. 3. Change in the Registered Office of the Company.
08 Aug 2024 Quarterly Results -
28 May 2024 Audited Results -
05 Mar 2024 Preferential issue of shares -
30 Jan 2024 Quarterly Results -
15 Dec 2023 Quarterly Results -
17 Oct 2023 Quarterly Results -
09 Aug 2023 Quarterly Results -
29 Apr 2023 Audited Results -
09 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
28 May 2022 Audited Results -
12 Feb 2022 Quarterly Results -
27 Jan 2022 Others Inter alia, 1. To consider the sale of shares/assets of the wholly owned subsidiary of the Company M/s. Trimurthi Foods Limited.
12 Nov 2021 Quarterly Results -
12 Aug 2021 Quarterly Results -
21 Jun 2021 Audited Results -
13 Feb 2021 Quarterly Results -
06 Nov 2020 Quarterly Results -
20 Aug 2020 Quarterly Results -
18 Jun 2020 Audited Results -
10 Feb 2020 Quarterly Results -
13 Nov 2019 Quarterly Results -
13 Aug 2019 Quarterly Results -
27 May 2019 Audited Results -
12 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
11 Aug 2018 Quarterly Results & Others Inter alia, (i) To Appoint Internal Auditors. (ii) Any other Business with the permission of Chair.
25 May 2018 Audited Results -
10 Feb 2018 Quarterly Results -
08 Jan 2018 Others Board has considered and approved to Invest the Funds of the Company in its Wholly Owned Subsidiary amounting to Rs. 75,00,000 (7,50,000 Shares of Rs. 10/- each).
13 Dec 2017 Quarterly Results (Revised)
05 Aug 2017 Quarterly Results -
19 May 2017 Audited Results -
13 Feb 2017 Quarterly Results -
05 Nov 2016 Quarterly Results Mr. Ram Swaroop Agarwal has tabled resignation letter before the board, the chairman has noted and the same and authorised Mr.Arun Kumar Bhangadia to search for Independent Director due to vacancy.
08 Aug 2016 Quarterly Results -
07 Jun 2016 Change in Directorate -
30 May 2016 Audited Results -
24 May 2016 Audited Results & Others To appoint consider fill the vacancy of women Director on the board caused by resignation of Ms. Priyanka Barve.
12 Feb 2016 Quarterly Results -
29 Dec 2015 Others 1. Consider change of name of the Company. 2. Consider change of objects of the Company subject to approval of Shareholders.
02 Nov 2015 Quarterly Results To review the performance of the Company.
01 Sep 2015 Resignation of Director -
13 Aug 2015 Quarterly Results To change of name of the Company from Trimurthi drugs & Pharmaceuticals Limited to "Trimurthi Industries Limited"
27 May 2015 Audited Results & Others 1. To take note of Disclosure of Interest of Directors. 2.. To take note of declaration by independent directors
11 Apr 2015 Others To consider the redesignation of the Mr. Arun kumar Bhangadia as Executive Chairman (Director) of the Company.
07 Feb 2015 Quarterly Results -
08 Nov 2014 Quarterly Results & Others To review the performance of the Company.
04 Sep 2014 Appointment of Co Secretary & CFO 1. To consider appointment of Internal Auditor. 2. To consider appointment of Secretarial Auditor. 3. To consider approval of annual accounts.
30 Jul 2014 Quarterly Results & Others -
24 May 2014 Audited Results -
30 Jan 2014 Quarterly Results & Others -
26 Jul 2013 Quarterly Results -
28 Jan 2013 Quarterly Results -
27 Oct 2012 Quarterly Results -
15 Sep 2012 Allotment of Convertible Warrants To allot convertible warrants to the non-promoters on preferential basis.
21 Jul 2012 Quarterly Results & Dividend To issue equity shares / convertible warrants to the promoters and others on preferential basis.
14 May 2012 Quarterly Results -
28 Jan 2012 Quarterly Results & Others The Company has entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export.
31 Oct 2011 Quarterly Results -
19 Aug 2011 Audited Results & Dividend -
29 Jul 2011 Quarterly Results -
28 Jan 2011 Quarterly Results -
30 Oct 2010 Quarterly Results -
07 Sep 2010 Review the progress of the Co. & Others To consider: 1. To review the progress of the company. 2. To consider and fix the Record date for consolidation of Equity Shares 3. To consider and take follow up action on the decisions taken at AGM.
30 Jul 2010 Consolidation of Shares & Others The Board has approved the consolidation of Shares from existing Re. 1/- paid up to Rs. 10/- paid-up & Revised the fund raising monetary limits of fund raising plan to Rs. 50 Crs.
23 Jul 2010 Audited, Quarterly Results & Dividend The Board has approved raising of additional Capital up to Rs. 25 Crs by issue of Equity based Securities to various investors by means of Public/Private Offerings/QIP Placement/Preferential Issue.
30 Apr 2010 Quarterly Results & Others The Board has decided to go for follow on public issue, subject to necessary permissions and approvals.
30 Jan 2010 Quarterly Results -
28 Oct 2009 Quarterly Results -
15 Sep 2009 Others To note the review of progress of the Company & to fix the record date for considering the stock split as approved by the Share holders, at the AGM of the Comapany held on held on September 07, 2009.
28 Aug 2009 Others The Board has discussed in detail MOU of SKF Life science & decided to cancel the MOU keeping in view of the current market condition & to open a Dividend Account with ING Vysya Bank Ltd.
25 Jul 2009 Audited, Qtr. Results, Dividend & Split To consider the sub-division of the each Equity Share of Rs 10/- each into 10 equity shares of Rs 1/- each & to appoint Sri. Arun Kumar Sarda as an Additional Independent Non executive Director.
18 Jun 2009 Others To note the review of progress of the Co., to enter into an MOU with SKF Life Sciences, Draft MOU can be obtained from the office of the Co. & to avail the licenses for chain of retail outlets.
28 Apr 2009 Quarterly Results -